Literature DB >> 24045348

Maori have worse outcomes after coronary artery bypass grafting than Europeans in New Zealand.

Tom Kai Ming Wang1, Tharumenthiran Ramanathan, Ralph Stewart, Sue Crengle, Greg Gamble, Harvey White.   

Abstract

AIMS: Disparities for Maori exist in New Zealand for cardiovascular risk factors, events and access to revascularisation. We compared characteristics and outcomes of coronary artery bypass grafting (CABG) between Maori and Europeans in New Zealand.
METHODS: Patients undergoing isolated CABG at Auckland City Hospital from July 2010-June 2012 were retrospectively analysed.
RESULTS: Of 818 patients, 82 were Maori and 444 were Europeans. Maori were younger (60.0 vs 67.9 years, p<0.001), had higher NZ deprivation index (8.5 vs 5.0, p<0.001), body mass index (32.6 vs 28.8 kg/m2, p<0.001), higher prevalence of heart failure (11.0% vs 2.3%, p<0.001), diabetes (43.9% vs 24.1%, p<0.001), smoking (39.0% vs 13.1%, p<0.001), dialysis (4.9% vs 0.9%, p=0.023), lower ejection fraction (p=0.001), lower additive EuroSCORE 1 (4.1 vs 4.8, p=0.041) and longer cardiopulmonary bypass time (100 vs 89 minutes p<0.001). Maori ethnicity was independently associated with 30-day mortality, odds ratio (OR) 6.35, 95% confidence interval 1.01-39.9, p=0.046; and surgical morbidity OR 2.05, 1.04-4.04, p=0.040. Maori had a trend for higher mortality at 1.4 plus or minus 0.6 years (hazards ratio 2.91, 0.92-9.20, p=0.069), 1-year mortality 6.3% vs 1.5%.
CONCLUSION: Despite being younger, Maori undergoing CABG had more comorbidities and socioeconomic deprivation. Maori had higher mortality and complication rates. Maori should have earlier access to CABG.

Entities:  

Mesh:

Year:  2013        PMID: 24045348

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  1 in total

1.  Postoperative mortality in New Zealand following general anaesthetic: demographic patterns and temporal trends.

Authors:  Jason K Gurney; Melissa McLeod; James Stanley; Doug Campbell; Luke Boyle; Elizabeth Dennett; Sarah Jackson; Jonathan Koea; Dick Ongley; Diana Sarfati
Journal:  BMJ Open       Date:  2020-09-24       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.